Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2004;103:1164-1173
© 2004 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Philip, J
Right arrow Articles by Jackson, L G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Philip, J
Right arrow Articles by Jackson, L G.
Related Collections
Right arrow Genetics and teratology
Right arrow Prenatal Diagnosis

ORIGINAL RESEARCH

Late First-Trimester Invasive Prenatal Diagnosis: Results of an International Randomized Trial

J Philip, MD*, R K. Silver, MD{dagger}, R D. Wilson, MD{ddagger}, E A. Thom, PhD§, J M. Zachary§, P Mohide, MD, M J. Mahoney, MD||, J L. Simpson, MD**, L D. Platt, MD{dagger}{dagger}, E Pergament, MD, PhD{ddagger}{ddagger}, D Hershey, MD§§, K Filkins, MD||||, A Johnson, DO¶¶, L P. Shulman, MD***, J Bang, MD*, S MacGregor, DO{dagger}, J R. Smith, MD, D Shaw, MB{ddagger}, R J. Wapner, MD{dagger}{dagger}{dagger} and L G. Jackson, MD{dagger}{dagger}{dagger} the NICHD EATA Trial Group*

From the *Rigshospitalet, Copenhagen, Denmark; {dagger}Evanston Hospital of Northwestern University Medical School, Evanston, Illinois; {ddagger}BC Women's Hospital, Vancouver, BC; §The Biostatistics Center, George Washington University, Rockville, Maryland; ¶McMaster University Medical Centre, Hamilton, Ontario; ||Yale University, New Haven, Connecticut; **Baylor College of Medicine, Houston, Texas; {dagger}{dagger}Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California; {ddagger}{ddagger}Department of Obstetrics and Gynecology, Northwestern University Medical School, Chicago, Illinois; §§Prenatal Diagnosis of Northern California Medical Group, Sacramento, California; ¶¶UCLA Center for the Health Sciences, Los Angeles, California; ||||Department of Obstetrics and Gynecology, Wayne State University, Detroit, Michigan; ***University of Tennessee, Memphis, Tennessee; and {dagger}{dagger}{dagger}Drexel University College of Medicine, Philadelphia, Pennsylvania.

Address reprint requests to: Laird Jackson, MD, Drexel University College of Medicine, Department of Obstetrics and Gynecology, Drexel University College of Medicine, Philadelphia, PA 19129; e-mail: lgj25{at}drexel.edu.

OBJECTIVE: To assess, in a randomized trial, the safety and accuracy of amniocentesis and transabdominal chorionic villus sampling (CVS) performed at 11–14 weeks of gestation, given that this time frame is increasingly relevant to early trisomy screening.

METHODS: We compared amniocentesis with CVS from 77 to 104 days of gestation in a randomized trial in a predominantly advanced maternal age population. Before randomization, the feasibility of both procedures was confirmed by ultrasonography, and experienced operators performed sampling under ultrasound guidance; conventional cytogenetic analysis was employed. The primary outcome measure was a composite of fetal loss plus preterm delivery before 28 weeks of gestation in cytogenetically normal pregnancies.

RESULTS: We randomized 3,775 women into 2 groups (1,914 to CVS; 1,861 to amniocentesis), which were comparable at baseline. More than 99.6% had the assigned procedure, and 99.9% were followed through delivery. In contrast to previous thinking, in the cytogenetically normal cohort (n = 3,698), no difference in primary study outcome was observed: 2.1% (95% confidence interval 1.5, 2.8) for CVS and 2.3% (95% confidence interval, 1.7, 3.1) for amniocentesis. However, spontaneous losses before 20 weeks and procedure-related, indicated terminations combined were increased in the amniocentesis group (P = .07, relative risk 1.74). We found a 4-fold increase in the rate of talipes equinovarus after amniocentesis (P = .02) overall and in week 13 (P = .03, relative risk = 4.65), but data were insufficient to determine this risk in week 14.

CONCLUSION: Amniocentesis at 13 weeks carries a significantly increased risk of talipes equinovarus compared with CVS and also suggests an increase in early, unintended pregnancy loss.

LEVEL OF EVIDENCE: I




This article has been cited by other articles:


Home page
Obstet GynecolHome page
R. K. Silver, R. D. Wilson, J. Philip, E. A. Thom, J. M. Zachary, P. Mohide, M. J. Mahoney, J. L. Simpson, L. D. Platt, E. Pergament, et al.
Late First-Trimester Placental Disruption and Subsequent Gestational Hypertension/Preeclampsia
Obstet. Gynecol., March 1, 2005; 105(3): 587 - 592.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
23 Apr 2004 to 23 Jul 2004
Evid. Based Nurs., October 1, 2004; 7(4): e4 - e4.
[Full Text] [PDF]


Home page
Evid. Based Med.Home page
Other articles noted
Evid. Based Med., September 1, 2004; 9(5): e5 - e5.
[Full Text] [PDF]


Home page
JWatch Women's HealthHome page
Early Amnio Increases Risk for Clubfoot and Pregnancy Loss
Journal Watch Women's Health, July 20, 2004; 2004(720): 1 - 1.
[Full Text]


Home page
JWatch GeneralHome page
Chorionic Villus Sampling vs. Early Amniocentesis: Which Is Safer?
Journal Watch (General), July 6, 2004; 2004(706): 3 - 3.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Obstetricians and Gynecologists.